Unit Price: | 300~500 USD |
---|---|
Payment Type: | T/T,L/C,D/P,D/A |
Incoterm: | FOB,CFR,CIF,EXW,FCA,CPT,CIP |
Min. Order: | 1 Kilogram |
Model No.: HRK-Edoxaban Tosylate
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Specification: 99%min
Certificate: Iso9001
Product Name: Hrk-Edoxaban Tosylate
CAS: 480449-70-5
MF: C24h30cln7o4s
MW: 738.27
Keywords: Chemicals Api Edoxaban 480449-70-5
Packaging: 1kg per bag. or customized packaging.
Productivity: 100000 kg
Transportation: Ocean,Land,Air,Express
Place of Origin: Shaanxi,China
Supply Ability: 100000 kg/months
Certificate: ISO
HS Code: N/A
Port: Guangzhou,Shanghai,Qingdao
Payment Type: T/T,L/C,D/P,D/A
Incoterm: FOB,CFR,CIF,EXW,FCA,CPT,CIP
Buy tablet 60 mg edoxaban tosylate monohydrate solubility
Product Name: Buy tablet 60 mg edoxaban tosylate monohydrate solubility
Appearance: white powder
CAS: 480449-70-5
MF: C24h30cln7o4s
MW:738.27
Storage: 2 Years
Shelf Life :Cool Dry Place
What is Edoxaban?
Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery.
Product Name | Buy tablet 60 mg edoxaban tosylate monohydrate solubility |
Appearance | White powder |
Test | HPLC |
Certificate | ISO 9001 |
specification | 99% min |
Keywords | Chemicals API Edoxaban 480449-70-5,Edoxaban Tosylate powder |
1.Edoxaban (tosylate Monohydrate) is used for Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
2. Limitations of use
Edoxaban (tosylate Monohydrate) should not be used in nonvalvular atrial fibrillation (NVAF) patients with a creatinine clearance (CrCl) greater than 95 mL/minute because of an increased risk of ischemic stroke compared to warfarin.
Xi'an Henrikang Biotech Co., Ltd., was established in May 2010, and located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Healthcare Products, Vitamin And Enzyme, Human Apis, Cosmetic Raw, Veterinary Products, Food Additives, plant extract and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.
For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.
Product Categories : Human APIs > Treatment for kidney disease